MD vs BKD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

MD

61.8
AI Score
VS
MD Wins

BKD

38.9
AI Score

Investment Advisor Scores

MD

62score
Recommendation
BUY

BKD

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric MD BKD Winner
Forward P/E 9.2937 45.6621 MD
PEG Ratio 0.2433 0.2804 MD
Revenue Growth 4.0% -8.9% MD
Earnings Growth 6.5% 0.0% MD
Tradestie Score 61.8/100 38.9/100 MD
Profit Margin 9.0% -4.7% MD
Beta 1.00 1.00 Tie
AI Recommendation BUY AVOID NEW MONEY MD

Relative Price Performance (Last 90 Days)

MD 1M: -3.4% · 3M: -5.3% BKD 1M: -7.8% · 3M: -29.4%

Current Technical Phase

MD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.3 · Price: $25.95

BKD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.5%), weak momentum, RSI 30

RSI (14): 29.8 · Price: $10.99

Fundamentals Snapshot

Metric MD BKD
Market Cap — —
Forward P/E 10.6 90.3
Trailing P/E 12.5 —
Revenue (TTM) — —
Revenue Growth 0.0% -0.1%
Gross Margin 0.3% 0.3%
Operating Margin 0.1% 0.1%
EPS 2.06 -0.58
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.